New Covenant Trust Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
588
+78
+15% +$37.4K 0.22% 74
2026
Q1
$251K Buy
510
+36
+8% +$19.5K 0.22% 78
2025
Q4
$281K Buy
474
+4
+0.9% +$2.26K 0.25% 62
2025
Q3
$228K Buy
+470
New +$219K 0.21% 80
2025
Q2
Sell
-486
Closed -$243K 90
2025
Q1
$243K Sell
486
-10
-2% -$5.42K 0.26% 75
2024
Q4
$257K Sell
496
-11
-2% -$6.05K 0.26% 71
2024
Q3
$312K Buy
507
+68
+15% +$40.3K 0.3% 57
2024
Q2
$235K Sell
439
-7
-2% -$4.01K 0.27% 66
2024
Q1
$259K Buy
+446
New +$250K 0.26% 62

Other funds holding TMO

New Covenant Trust Company's TMO Position: Q2 2026 in Review

New Covenant Trust Company increased its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, buying an estimated $37.4K and bringing the position to 588 shares worth $295K. The position accounts for 0.22% of the portfolio, ranked #74.

New Covenant Trust Company first reported a position in TMO in Q1 2024 and has held it in 9 quarters since. The position peaked at $312K in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • New Covenant Trust Company held 588 shares of Thermo Fisher Scientific worth $295K as of Q2 2026.
  • New Covenant Trust Company bought 78 Thermo Fisher Scientific shares in Q2 2026, an estimated $37.4K.
  • Thermo Fisher Scientific made up 0.22% of New Covenant Trust Company's portfolio in Q2 2026, its #74 holding.
  • New Covenant Trust Company first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 9 quarters since.
  • New Covenant Trust Company's Thermo Fisher Scientific position peaked at $312K in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.